DAFNA Capital Management LLC - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$10,382,000
+179.3%
376,993
+67.3%
2.17%
+146.1%
Q1 2021$3,717,000
-10.5%
225,3930.0%0.88%
-28.6%
Q4 2020$4,154,000
+59.8%
225,393
+18.1%
1.24%
+46.3%
Q3 2020$2,599,000
+77.5%
190,930
+6.2%
0.84%
+68.0%
Q4 2019$1,464,000
-59.4%
179,845
-50.6%
0.50%
-63.0%
Q3 2019$3,610,000
+60.3%
364,229
+104.3%
1.36%
+60.3%
Q2 2019$2,252,000
+31.2%
178,306
-22.1%
0.85%
-0.8%
Q4 2018$1,717,000
+13.2%
228,939
+50.9%
0.85%
+37.1%
Q3 2018$1,517,000
+499.6%
151,739
+658.7%
0.62%
+428.0%
Q2 2018$253,00020,0000.12%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,833,120$52,169,0008.78%
Copernicus Capital Management, LLC 227,719$3,099,0002.95%
FRAZIER MANAGEMENT LLC 2,182,789$29,708,0002.67%
Baupost Group 18,044,239$242,393,0002.62%
Prosight Management, LP 282,100$3,839,0001.83%
RTW INVESTMENTS, LP 3,745,286$50,973,0001.23%
GREAT POINT PARTNERS LLC 943,339$12,839,0001.16%
DAFNA Capital Management LLC 190,930$2,599,0000.84%
Endurant Capital Management LP 176,710$2,405,0000.71%
Artal Group S.A. 1,400,000$19,054,0000.46%
View complete list of TRANSLATE BIO INC shareholders